Cost Assessment Panel

HA has established a ‘Cost Assessment Panel’ to negotiate with pharmaceutical companies, evaluate the cost effectiveness of a new drug and its total cost impact, striving to reduce the costs of introducing new drugs, which are mostly patent-protected. HA also invites Experts to commission health economic evaluation studies, if required, for comprehensive evaluation of a new drug.